Subgroup | number of participants/ number of events | Person-Years (years) | Adjusted HR (95%CI) | P for interaction |
---|---|---|---|---|
Gender | Â | Â | Â | 0.380 |
Male | 632/9,080 | 43940.42 | 1.10 (0.97, 1.24) | Â |
Female | 433/9,512 | 46371.25 | 1.19 (1.04, 1.35) | Â |
Race/ethnicity | Â | Â | Â | 0.010 |
Non-Hispanic White | 606/7,738 | 37867.50 | 1.21 (1.07, 1.37) | Â |
Non-Hispanic Black | 258/4,844 | 23902.17 | 0.87 (0.72, 1.05) | Â |
Mexican American | 92/2,975 | 14063.42 | 1.32 (0.96, 1.82) | Â |
Other races | 109/3,035 | 14478.58 | 1.44 (1.03, 2.03) | Â |
Age | Â | Â | Â | 0.931 |
< 60 years | 263/13,051 | 65725.00 | 1.35 (1.14, 1.59) |  |
≥ 60 years | 802/5,541 | 24586.67 | 1.34 (1.20, 1.49) |  |
Diabetes | Â | Â | Â | 0.842 |
Yes | 350/2,898 | 13050.25 | 1.14 (1.02, 1.28) | Â |
No | 715/15,694 | 77261.42 | 1.12 (0.95, 1.32) | Â |
Stroke | Â | Â | Â | 0.393 |
Yes | 141/693 | 2895.58 | 1.15 (1.04, 1.27) | Â |
No | 924/17,899 | 87416.08 | 1.02 (0.78, 1.32) | Â |
Coronary heart disease | Â | Â | Â | 0.703 |
Yes | 167/725 | 2958.75 | 1.13 (1.02, 1.26) | Â |
No | 898/17,867 | 87352.92 | 1.08 (0.86, 1.36) | Â |
Renal failure | Â | Â | Â | 0.075 |
Yes | 96/629 | 2798.00 | 1.16 (1.05, 1.28) | Â |
No | 969/17,963 | 87513.67 | 0.87 (0.65, 1.17) | Â |
Hypertension | Â | Â | Â | 0.821 |
Yes | 702/6,714 | 31562.75 | 1.09 (0.93, 1.28) | Â |
No | 363/11,878 | 58748.92 | 1.12 (0.99, 1.26) | Â |
Myocardial infarction | Â | Â | Â | 0.136 |
Yes | 168/758 | 3143.00 | 1.16 (1.04, 1.28) | Â |
No | 897/17,834 | 87168.67 | 0.95 (0.75, 1.21) | Â |
Cancer | Â | Â | Â | 0.001 |
Yes | 279/1,783 | 7888.42 | 1.23 (1.11, 1.37) | Â |
No | 786/16,809 | 82423.25 | 0.88 (0.74, 1.06) | Â |
Body mass index | Â | Â | Â | 0.106 |
< 25 kg/m2 | 335/5,021 | 24985.33 | 1.17 (0.98, 1.39) |  |
25–29.9 kg/m2 | 330/5,903 | 28919.75 | 1.53 (1.27, 1.85) |  |
≥ 30 kg/m2 | 390/7,648 | 36330.75 | 1.28 (1.09, 1.51) |  |
Liver diseases | Â | Â | Â | 0.834 |
Yes | 96/777 | 3428.42 | 1.13 (1.02, 1.25) | Â |
No | 969/17,815 | 86883.25 | 1.10 (0.78, 1.57) | Â |